Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
19.32
-2.23 (-10.35%)
Nov 4, 2026, 11:17 AM EST - Market open
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $234.28 million as of November 4, 2026. Its market cap has decreased by 45.28% in one year.
Market Cap
234.28M
Enterprise Value
14.39M
1-Year Change
-45.28%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $234.28M, an increase of 460.71%. That is a compound annual growth rate of 35.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 234.28M | -62.64% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 576.96M |
| Geron | 574.63M |
| MiMedx Group | 566.19M |
| Shattuck Labs | 558.02M |
| Entera Bio | 556.55M |
| Neurogene | 551.31M |
| Puma Biotechnology | 538.91M |
| Valneva SE | 519.43M |